Health NGO Urges Future Dutch Govt To Act On High Drug Prices
Executive Summary
As the Dutch elections draw near, the civil society body Health Action International has launched a campaign calling on a future government to tackle what it calls “soaring” drug prices. The move follows the adoption of a European Parliament Resolution demanding a better balance between public health imperatives and industry interests.
You may also be interested in...
MEPs And Health Advocates Pile The Pressure On EU Drug Pricing
A European Parliament committee has approved a report outlining some possible solutions to the question of access to expensive new drugs, while Health Action International and several other NGOs have put emphasis on the need to ensure that where drugs developed by private companies use publicly funded research, they really serve the public good.
WHO Launches Twin-Track Procedure To Speed Access To Health Products
A procedure used to accelerate the approval of COVID-19 products during the pandemic is to be applied to all medicines using “synchronized and parallel, but otherwise entirely independent, processes,” the World Health Organization says.
'Don't Compromise The Pharma Innovation System,' Says Outgoing IFPMA Head Thomas Cueni
Thomas Cueni is stepping down after seven years at the helm of the International Federation of Pharmaceutical Manufacturers and Associations. In an interview with the Pink Sheet ahead of his retirement, he reflects on the proposed pandemic treaty, what still needs to be done to ensure equitable access to medicines, the importance of tackling AMR, moves towards regulatory reliance – and what his post-IFPMA life might look like.